Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction

Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction

The aim of this study was to investigate whether the VKORC1*3 (rs7294/9041 G > A), VKORC1*4 (rs17708472/6009 C > T), and CYP4F2 (rs2108622/1347 C > T) polymorphisms were associated with elevated warfarin maintenance dose requirements in patients with myocardial infarction (n=105) from the W...

Full description

Bibliographic Details
Main Authors:	Marianne K. Kringen, Kari Bente Foss Haug, Runa M. Grimholt, Camilla Stormo, Sigrid Narum, Mimi S. Opdal, Jan Toralf Fosen, Armin P. Piehler, Per W. Johansen, Ingebjørg Seljeflot, Jens Petter Berg, Odd Brørs
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	Journal of Biomedicine and Biotechnology
Online Access:	http://dx.doi.org/10.1155/2011/739751

Similar Items

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
by: Seljeflot Ingebjørg, et al.
Published: (2008-06-01)

Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.
by: Marianne K Kringen, et al.
Published: (2014-01-01)

Copy number variations of the ATP-binding cassette transporter <it>ABCC6</it> gene and its pseudogenes
by: Kringen Marianne K, et al.
Published: (2012-08-01)

VKORC1 variants as significant predictors of warfarin dose in Emiratis
by: Al-Mahayri ZN, et al.
Published: (2019-04-01)

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017-03-01)

A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats☆
by: Michael H. Kohn, et al.
Published: (2008-11-01)

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
by: Behzad Poopak, et al.
Published: (2016-02-01)

PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients
by: Taofik Rusdiana, et al.
Published: (2012-01-01)

VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients
by: Sea Mi Park, et al.
Published: (2013-05-01)

The accuracy of warfarin dosage based on VKORC1 and CYP2C9 phenotypes in a Chinese population
by: Agustinus Wijaya, et al.
Published: (2012-05-01)

Methylation of CYP1A1 and VKORC1 promoter associated with stable dosage of warfarin in Chinese patients
by: Shiwei He, et al.
Published: (2021-06-01)

Frequency of two VKORC1 gene variants and its correlation with warfarin maintenance dose
by: esmat khaleqsefat, et al.
Published: (2018-12-01)

Evaluation of the VKORC 1 and CYP2C9 Gene Polymorphisms and Their Effects on the Emergency Complications in the Patients Using Warfarin
by: Oğuz Yardım, et al.
Published: (2017-06-01)

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.
by: Andrea L Jorgensen, et al.
Published: (2012-01-01)

Warfarin Dosing in a Patient with CYP2C9*3*3 and VKORC1-1639 AA Genotypes
by: Mark Johnson, et al.
Published: (2014-01-01)

Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy
by: Laith N. AL-Eitan, et al.
Published: (2019-05-01)

The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
by: Cindi, Zinhle
Published: (2019)

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People
by: Lindsay M. Henderson, et al.
Published: (2019-05-01)

VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker.
by: Ramasamy Saminathan, et al.
Published: (2010-12-01)

Evaluation of CYP2C9 and VKORC1 gene variants that may result in warfarin dosage sensitivity and poor pregnancy outcomes
by: Mitchell, Cathrine
Published: (2008)

Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit
by: Mansij Biswas, et al.
Published: (2018-12-01)

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
by: Fumihiko Takeuchi, et al.
Published: (2009-03-01)

Novel mutations in the VKORC1 gene of wild rats and mice – a response to 50 years of selection pressure by warfarin?
by: Jäkel Thomas, et al.
Published: (2009-02-01)

Allele and genotype frequencies of the two single nucleotide polymorphisms in the VKORC1 gene that are most important for warfarin treatment among Emiratis
by: Hayat S Al-Jaibeji, et al.
Published: (2016-01-01)

The effect of CYP2C9*2, CYP2C9*3, and VKORC1-1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah
by: Zohreh Hosseinkhani, et al.
Published: (2018-01-01)

Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
by: Silveira MMBM, et al.
Published: (2019-08-01)

Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation
by: Jiao Li, et al.
Published: (2018-05-01)

Impact of <i>CYP2C9</i> and <i>VKORC1</i> Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy
by: Laith N. AL-Eitan, et al.
Published: (2018-11-01)

Field trials to assess resistance to warfarin and difenacoum of house mice in relation to the occurrence of variants in the vkorc1-gene before and after the treatments
by: Endepols, S., et al.
Published: (2011-10-01)

A New Nested Allele-Specific Multiplex Polymerase Chain Reaction Method for Haplotyping of VKORC1 Gene to Predict Warfarin Sensitivity
by: Yung An Chua, et al.
Published: (2014-01-01)

A New Nested Allele-Specific Multiplex Polymerase Chain Reaction Method for Haplotyping of VKORC1 Gene to Predict Warfarin Sensitivity
by: Yung, An Chua, et al.
Published: (2014)

Value of VKORC1 (−1639G>A) rs9923231 genotyping in predicting warfarin dose: A replication study in South Indian population
by: S. Harikrishnan, et al.
Published: (2018-12-01)

Proteininteraktionen der Vitamin K Epoxid Reduktase Proteine VKORC1 und VKORC1L1
by: Schaafhausen, Anne
Published: (2011)

The role of warfarin pharmacogenomics on the time it takes to reach stable therapeutic International Normalized Ratio (INR) and on warfarin dose required to maintain stable therapeutic INR in Black African and Mixed Ancestry South Africans: a focus on CYP2C9 and VKORC1
by: Makambwa, Edson
Published: (2020)

The allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population
by: Fariba Emadian Razavi, et al.
Published: (2017-01-01)

Distribution and consequences of VKORC1 polymorphisms in Germany
by: Runge, M., et al.
Published: (2011-10-01)

VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
by: Johannes Oldenburg, et al.
Published: (2015-07-01)

Structural Modeling Insights into Human VKORC1 Phenotypes
by: Katrin J. Czogalla, et al.
Published: (2015-08-01)

Gene expression results in lipopolysaccharide-stimulated monocytes depend significantly on the choice of reference genes
by: Øvstebø Reidun, et al.
Published: (2010-05-01)

Genotyping of CYP2C9 and VKORC1 in the Arabic Population of Al-Ahsa, Saudi Arabia
by: Abdullah M. Alzahrani, et al.
Published: (2013-01-01)